Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
30 studies found for:    " May 11, 2011":" June 10, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa
Conditions: HIV;   Impaired Cognition
Interventions: Drug: standard care;   Drug: novel treatment
22 Completed Therapy to Elevate CD4 Counts in HIV-1 Disease
Condition: HIV Disease
Intervention: Biological: alpha-1-Proteinase Inhibitor
23 Unknown  Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
Condition: HIV Positive
Intervention: Drug: Vorinostat
24 Completed Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: BI 201335
25 Completed Effects of Manualized Treatment in a Seamless System
Conditions: Substance Abuse;   Offenders;   Criminal Thinking;   HIV Risk Behaviors
Intervention: Behavioral: Cognitive Behavioral Therapy
26 Terminated Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)
Condition: HIV-1 Infection
Interventions: Drug: MK-1972;   Drug: Placebo to MK-1972
27 Completed Data Analysis for 04-C-0234 Tenofovir Disoproxil Fumarate Salvage Therapy in HIV-Infected Children and a Study of Its Effect on Bone Metabolism
Condition: HIV-Infected Children
Intervention:
28 Completed Nurse Delivered Cell Phone Adherence Intervention (Pick It UP)
Condition: Medication Adherence
Interventions: Behavioral: Adherence Counseling;   Behavioral: General Health Counseling;   Behavioral: Text Messages
29 Completed Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel
Condition: Prevention
Intervention: Drug: Tenofovir 1% vaginal gel
30 Completed Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk
Conditions: Cardiovascular Diseases;   Hyperlipidemia;   Obesity
Interventions: Behavioral: Physical Activity Group;   Other: Standard Care Group

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-30) Next Page   
Indicates status has not been verified in more than two years